Related Experiment Video
Updated: Mar 28, 2026

Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
High-Affinity Interaction of the K-Ras4B Hypervariable Region with the Ras Active Site
Tanmay S Chavan1, Hyunbum Jang2, Lyuba Khavrutskii2
1Medicinal Chemistry Department, University of Illinois at Chicago, Chicago, Illinois; Biochemistry and Molecular Genetics Department, University of Illinois at Chicago, Chicago, Illinois.
The C-terminal hypervariable region (HVR) of K-Ras4B directly interacts with its active site, regulating signaling pathways. This interaction offers a new therapeutic target for KRAS-dependent cancers.
Area of Science:
- Molecular biology
- Cell signaling
- Oncology
Background:
- Ras proteins are key signal transducers.
- KRAS is a frequently mutated oncogene in human cancers.
- The C-terminal hypervariable region (HVR) of Ras proteins was thought to have minimal impact on the catalytic domain.
Purpose of the Study:
- To investigate the role of the K-Ras4B C-terminal HVR in protein signaling.
- To determine the interaction between K-Ras4B HVR and its active site.
- To explore the therapeutic potential of targeting the K-Ras HVR-active site interaction.
Main Methods:
- Biochemical assays to study protein interactions.
- Analysis of K-Ras4B HVR binding affinity to different Ras states.
- Investigation of the functional consequences of HVR binding on Ras signaling pathways.
Main Results:
- The K-Ras4B HVR directly interacts with the protein's active site.
- This interaction is significantly stronger with GDP-bound K-Ras compared to GTP-bound K-Ras.
- HVR binding modulates Ras-Raf interactions, phospholipid binding, and nucleotide exchange, revealing essential regulatory roles.
Conclusions:
- Contrary to previous models, the K-Ras4B HVR plays a critical role in regulating K-Ras signaling.
- The high-affinity binding of HVR peptide analogs to the K-Ras active site suggests a viable therapeutic strategy.
- Targeting this interaction with synthetic molecules could be effective for treating KRAS-dependent tumors.
More Related Videos
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
06:44Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Receptor Tyrosine Kinases
The Ras Gene
Abnormal Proliferation